Martin L Campbell

Title: Martin L Campbell: Innovator in Peptide Antigens

Introduction

Martin L Campbell is a notable inventor based in Colorado Springs, CO (US). He has made significant contributions to the field of peptide antigens, holding 2 patents that showcase his innovative approach to immunogenicity.

Latest Patents

One of his latest patents focuses on the controlled modulation of amino acid side chain length of peptide antigens. This invention provides a method for creating peptide antigens that include epitopes with modifications to the amino acid side chain. By extending or shortening the side chain using CH3/CH2 groups, and employing computer-assisted modeling of tumor antigens bound in the MHC-I-groove, the immunogenicity of these antigens can be enhanced. This method allows for minimal alterations to the adjacent tertiary structure, thereby reducing the risk of cross-reactivity. The invention also outlines methods for therapeutic or prophylactic treatment of various conditions through the administration of these antigens.

Career Highlights

Throughout his career, Martin has worked with esteemed organizations such as the University of Texas System and the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. His work has significantly impacted the field of immunology and peptide research.

Collaborations

Martin has collaborated with notable colleagues, including Constantin G Ioannides and Catherine A O'Brian. These partnerships have further enriched his research and contributions to the scientific community.

Conclusion

Martin L Campbell stands out as an innovative inventor in the realm of peptide antigens, with a focus on enhancing immunogenicity through his patented methods. His work continues to influence therapeutic approaches in medicine.